Navigation Links
Obesity And Environmental Chemicals: Research Probes Potential Link

A team of researchers is investigating whether the increasing ubiquity of chemical flame-retardants might be related to the climbing rate of obesity// in the United States.

“Environmental chemicals are a possible third component to the obesity epidemic, along with diet and exercise,” says Gale Carey, professor of nutrition and a leader of the research project, along with professor of nutrition Anthony Tagliaferro and Deena Small, assistant professor of molecular biology and biochemistry. The trio received funding for the project from the President’s Excellence Initiative Awards, which provide support for interdisciplinary research.

The flame retardants, called polybrominated diphenyl ethers (PBDEs), have been produced since the 1960s; they’re now found in consumer products like carpeting, upholstered furniture, computers and hair dryers, where they retard the combustibility of these products. It’s estimated that American consumers come into contact with up to 100 products containing PBDEs per day.

While chemical manufacturers say PBDEs can reduce by 45 percent the risk of death and injury by fire, they are an emerging environmental chemical – and an emerging concern, as their impact on the human body becomes documented. Their persistence in the environment has PBDEs compared to now-banned toxins like PCBs and DDT; the use of two types of PBDEs is prohibited in European Union countries.

Carey, Small and Tagliaferro, working in collaboration with clinical assistant professor of animal science Alice Roudabush, D.V.M., and 11 undergraduate and graduate student researchers, are exploring how PBDEs affect fat storage and production. “We know PBDEs are fat-soluble – they dissolve in fat tissue,” says Carey. “What are they doing in the fat as they sit there? Nobody has asked that question yet.”

Building on research conducted by two of Carey’s graduate students, the faculty trio will expose laboratory rats to PBDEs through pregnancy and lactation, stages Carey describes as critical windows for exposure. At the molecular level, Small will examine what PBDEs are doing to stem cell populations within the adipose tissue and the effects of PBDEs on gene expression. Does exposure to PBDEs, which mimic estrogen and thyroid hormones in the body, make cells more likely to develop into fat cells? “Everything I do has to do with how changes in signaling result in changes in gene expression,” she says.

Carey’s work is at the cellular level. Isolating the fat tissue of these animals, Carey will explore the insulin sensitivity of fat cells. Preliminary data from her lab suggest that chronic exposure to PBDEs could cause fat cells to become less sensitive to insulin, which is a forerunner to developing Type II diabetes. The fat cells of growing male rats that were fed PBDEs daily for a month acted metabolically like the fat cells of obese rats, although the PBDE-fed rats weighed the same as a control group.

Tagliaferro, whose research interests concern whole-body energy and metabolism questions, will assess sensitivity of all body tissues to insulin, as well as examine the food intake, body weight changes, and energy metabolism of the rat pups once they are weaned from their mothers. PBDEs, the researchers note, seem to interrupt thyroid hormone levels, which may impact caloric expenditure.

“There’s much more to obesity than eating too much McDonald’s and not exercising,” says Small. “PBDEs may be one of the confounding factors to obesity.”

With the research just getting underway, the scientists are duly cautious about predicting outcomes. If findings implicate PBDEs in obesity, Carey notes, the news would be good and bad.

“From a scientific standpoint, it would be very interesting if these animals began to put on weight,” she says. “But part of me hopes they don’t, because these chemicals are all around. But that’s the good thing about science: You try to get to the truth, and then when you get the truth, you can do something about it.”

SourceBio-Bio Technology

Related medicine news :

1. Lean Protein Could Be Key to Obesity Drugs
2. Obesity raises IVF miscarriage risk
3. Obesity a risk for pancreatic cancer
4. Obesity shortens lifespan
5. Is Obesity a risk factor?
6. Obesity a global problem
7. Obesity increases health costs
8. Obesity in children a risk factor for diabetes
9. Decrease of Hunger Hormone after Obesity Surgery
10. Obesity risk for immobilized adults
11. Obesity risk can be reduced by eating breakfast regularly
Post Your Comments:

(Date:12/1/2015)... ... December 01, 2015 , ... ... and hematology continuing medical education (CME), today announced that the first annual School ... New York. , “The prevention, detection and treatment of gastrointestinal cancers are undergoing ...
(Date:12/1/2015)... , ... December 01, 2015 , ... Growth in medical ... due to decreases in utilization of hospital and nonhospital care, according to a recent ... Medical Benchmarks for Louisiana, 16th Edition , found medical payments per claim with more ...
(Date:12/1/2015)... ... December 01, 2015 , ... ... images have been lifted as IMAGE Information Systems launches MED-TAB™ -- the world’s ... America Annual Meeting from November 29 to December 4, 2015. , MED-TAB ...
(Date:12/1/2015)... ... December 01, 2015 , ... ... Inc. (“Visage”), a wholly owned subsidiary of Pro Medicus Ltd. (ASX: PME), has ... the Radiological Society of North America (RSNA) 2015 annual meeting through December 3 ...
(Date:12/1/2015)... (PRWEB) , ... December 01, 2015 , ... ... clinical solutions for the care management and population health arenas, is pleased to ... clinical and cost containment services, has successfully implemented the ACUITY Complete Care™ Management ...
Breaking Medicine News(10 mins):
(Date:12/1/2015)... , Dec. 2, 2015  A combination of detailed ... the first time in the surgical planning for separation of ... annual meeting of the Radiological Society of North ... --> Conjoined twins, or twins whose bodies are connected, ... rates are low and separating them through surgery is extremely ...
(Date:12/1/2015)... , Dec. 1, 2015  A large study ... drug tamoxifen while taking an antidepressant found no increased ... today in The Journal of the National Cancer Institute. ... Tamoxifen is a commonly prescribed generic drug taken by ... developing a recurrence. Tamoxifen is recommended for five years, ...
(Date:12/1/2015)... Wash. and VANCOUVER , ... Committee (DMC) meeting, OncoGenex Pharmaceuticals, Inc. (NASDAQ: OGXI ... is continuing based on the pre-planned interim futility analysis ... review, no new safety issues were identified by the ... all analyses and final results are expected in the ...
Breaking Medicine Technology: